K 2007 Preview: Back to the future (Modern Plastics)
Three tumultuous years have passed since K 2004. The themes are familiar: worldwide competition, rising resin prices, added value, industry consolidation, and offshoring, to name just a few. At K, though, the focus is squarely on the future. And as you might have guessed, the future is now.

FDA to extend review of Biogen's Tysabri (BizJournals)
Cambridge-based Biogen Idec Inc. has suffered a temporary setback in its goal to have 100,000 patients taking Tysabri in the coming years.